Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Long-term Investment Intensity
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Long-term Investment Intensity of 10.2% as of September 2019. Long-term investments of CN¥800.80 Million represent 10.2% of total assets of CN¥7.84 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shenzhen Salubris Pharmaceuticals Co Ltd Long-term Investment Intensity (2016–2018)
This chart shows how Shenzhen Salubris Pharmaceuticals Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 10.2%, reflecting long-term investments of CN¥800.80 Million against total assets of CN¥7.84 Billion CNY. For the complete balance sheet picture, see balance sheet size of Shenzhen Salubris Pharmaceuticals Co Ltd.
Annual Long-term Investment Intensity for Shenzhen Salubris Pharmaceuticals Co Ltd (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shenzhen Salubris Pharmaceuticals Co Ltd from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Shenzhen Salubris Pharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 9.1% | CN¥718.04 Million | CN¥7.90 Billion | ▲ +4.4 pp |
| 2017 | 4.7% | CN¥324.76 Million | CN¥6.86 Billion | ▲ +4.1 pp |
| 2016 | 0.7% | CN¥44.26 Million | CN¥6.53 Billion | — |